Galactoxylomannan does not exhibit cross-reactivity in the Platelia Aspergillus enzyme immunoassay

被引：14

作者：

De Jesus, Magdia

Hackett, Emily

Durkin, Michelle

Connolly, Patricia

Casadevall, Arturo

Petraitiene, Ruta

Walsh, Thomas J.

Wheat, L. Joseph

机构：

[1] MiraVista Diagnost, Indianapolis, IN 46241 USA

[2] Yeshiva Univ Albert Einstein Coll Med, Bronx, NY 10461 USA

[3] NCI, CRC, Immunocompromised Host Sect, Pediat Oncol Branch, Bethesda, MD 20892 USA

[4] SAIC Frederick Inc, Lab Anim Sci Program, Frederick, MD 21702 USA

来源：

CLINICAL AND VACCINE IMMUNOLOGY | 2007年 / 14卷 / 05期

关键词：

D O I：

10.1128/CVI.00368-06

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Given the recent report of a false-positive result in the Platelia Aspergillus enzyme immunoassay in a patient with cryptococcosis and in yeast extracts and purified galactoxylomannan of Cryptococcus neoformans, we evaluated culture extracts, purified polysaccharides, clinical specimens, and specimens from animals following experimental infection. Our results revealed no cross-reactions.

引用

页码：624 / 627

页数：4

共 50 条

[41] Cross-reactivity of a Histoplasma capsulatum antigen enzyme immunoassay in urine specimens from persons with emergomycosis in South Africa
Maphanga, Tsidiso G.
Naicker, Serisha D.
Gomez, Beatriz L.
Mhlanga, Mabatho
Mpembe, Ruth S.
Schwartz, Ilan S.
Bamford, Colleen
Nel, Jeremy
Govender, Nelesh P.
MEDICAL MYCOLOGY, 2021, 59 (07) : 672 - 682
[42] Cross-reactivity of TDX and OPUS immunoassay systems for serum digoxin determination
Okazaki, M
Tanigawara, Y
Kita, T
Komada, F
Okumura, K
THERAPEUTIC DRUG MONITORING, 1997, 19 (06) : 657 - 662
[43] Demonstration of the mechanism for phenomenon of suppression of immunoassay results caused by cross-reactivity
Jortani, SA
Steimer, W
Reynolds, K
Womack, EP
Barnes, W
Brookhart, PP
Doss, RC
Valdes, R
THERAPEUTIC DRUG MONITORING, 2005, 27 (02) : 223 - 224
[44] Evaluation of a LoNv cross-reactivity cyclosporine a (CsA) immunoassay for the architect® analyzer
Wong, P. Y.
Liao, M.
Wang, Y.
Spring, T.
Brate, E.
Holets-McCormack, S.
Wang, P.
Pacenti, D.
Piktel, R.
THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 505 - 505
[45] Cross-Reactivity of Phentermine with an Immunoassay Designed to Detect Amphetamine in a Meconium Specimen
Marin, Stephanie J.
Moore, Christine
McMillin, Gwendolyn A.
CLINICAL CHEMISTRY, 2009, 55 (03) : 589 - 590
[46] Development of a low cross-reactivity cyclosporine a (CsA) immunoassay for the abbott ARCHITECT®
Spring, T.
Brate, E.
Holets-McCormack, S.
Wang, P.
Pacenti, D.
Piktel, R.
Wong, P. Y.
Wang, Y.
Liao, M.
CLINICAL BIOCHEMISTRY, 2008, 41 (03) : 193 - 193
[47] Development of an Abbott ARCHITECT cyclosporine immunoassay without metabolite cross-reactivity
Brate, Elaine M.
Finley, David M.
Grote, Jonathan
Holets-McCormack, Shelley
Ozaeta, Pan F.
Pacenti, David
Peart, Joan E.
Piktel, Ryan E.
Ramsay, Carol S.
Rupprecht, Kevin R.
Saldana, Sylvia C.
Spring, Thomas G.
Tetin, Sergey Y.
Trudeau, Beth C.
Wang, Phil
Xie, Helen
CLINICAL BIOCHEMISTRY, 2010, 43 (13-14) : 1152 - 1157
[48] Mucositis does not lead to false-positivity of the Platelia Aspergillus enzyme-linked immunosorbent assay
Z. Racil
I. Kocmanova
B. Weinbergerova
M. Toskova
J. Winterova
M. Lengerova
L. Buresova
S. Timilsina
J. Mayer
European Journal of Clinical Microbiology & Infectious Diseases, 2010, 29 : 851 - 855
[49] Mucositis does not lead to false-positivity of the Platelia Aspergillus enzyme-linked immunosorbent assay
Racil, Z.
Kocmanova, I.
Weinbergerova, B.
Toskova, M.
Winterova, J.
Lengerova, M.
Buresova, L.
Timilsina, S.
Mayer, J.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2010, 29 (07) : 851 - 855
[50] Cross-reactivity of Aspergillus galactomannan in an HIV-infected patient with histoplasmosis
Min, Zaw
Baddley, John W.
Rodriguez, Jorge M.
Moser, Stephen A.
Patel, Mukesh
MEDICAL MYCOLOGY CASE REPORTS, 2012, 1 (01): : 119 - 122

← 1 2 3 4 5 →